Literature DB >> 15019304

Transplacental exposure to the DNA demethylating agent, 5-AZA-CdR, affects the sexual behavior of CD-1 male mice.

Francisco J Cisneros1, Stacy Branch.   

Abstract

Intrauterine exposure to 5-AZA-2'-deoxycytidine (5-AZA-CdR) alters gene expression causing malformations, abnormal post-natal growth and altered reproductive capacity. To elucidate whether the phenomenon observed in 5-AZA-CdR in utero exposed male mice was a behavioral alteration, at gestation day (GD) 10, CD-1 pregnant mice were administered 1mg/kg i.p. of 5-AZA-CdR or saline solution. After parturition, the number and sex of pups were recorded. While litter size was not affected, the ratio of male to female offspring was altered in treated mice. To determine whether the phenotypic observation of male gender corresponded to the appropriate genotype, presence of Sry gene in 5-AZA-CdR F1 males was determined. At 3 months of age, the male sexual behavior test outlined by Chubb was conducted. Presence of vaginal plug and pregnancy were determined in the natural breeding phase. Mount latency and number of mounts per mouse were assessed in the behavioral test phase. In utero exposed male mice resulted in diminished mating behavior (as measured by vaginal plug presence, mount latency and number of mounts) and reduced sexual interest while exposed to a receptive female. While normal presence of Sry gene was observed, mating behavior was altered in exposed males suggesting that the reproductive alteration could be attributed to a behavioral phenomenon.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15019304     DOI: 10.1016/j.neuro.2003.09.002

Source DB:  PubMed          Journal:  Neurotoxicology        ISSN: 0161-813X            Impact factor:   4.294


  4 in total

Review 1.  Epigenetic underpinnings of developmental sex differences in the brain.

Authors:  Bridget M Nugent; Margaret M McCarthy
Journal:  Neuroendocrinology       Date:  2011-03-11       Impact factor: 4.914

Review 2.  Epigenetic medicine and fetal alcohol spectrum disorders.

Authors:  Marisol Resendiz; Yuanyuan Chen; Nail C Oztürk; Feng C Zhou
Journal:  Epigenomics       Date:  2013-02       Impact factor: 4.778

3.  Bone loss in adult offspring induced by low-dose exposure to teratogens.

Authors:  Arkady Torchinsky; Limor Mizrahi; Shoshana Savion; Ron Shahar; Vladimir Toder; Eugene Kobyliansky
Journal:  J Bone Miner Metab       Date:  2011-09-30       Impact factor: 2.626

4.  The European Medicines Agency Review of Decitabine (Dacogen) for the Treatment of Adult Patients With Acute Myeloid Leukemia: Summary of the Scientific Assessment of the Committee for Medicinal Products for Human Use.

Authors:  Maria Nieto; Pierre Demolis; Eliane Béhanzin; Alexandre Moreau; Ian Hudson; Beatriz Flores; Henry Stemplewski; Tomas Salmonson; Christian Gisselbrecht; David Bowen; Francesco Pignatti
Journal:  Oncologist       Date:  2016-04-18
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.